Future Events
The benefits of routine-based ...
Join leading experts for this free webinar on 16 May 2023.
RegisterFever in returning travellers
ISAC is pleased to announce the launch of a second free E-module which has been developed as part of a ...
More info32nd International Congress of ...
Watch the recording of Plenary 2: Treatment of multidrug resistant Pseudomonas aeruginosa infections by Prof. Juan-Pablo Horcajada
Read more32nd International Congress of ...
Watch the recording of the opening lecture from the 32nd International Congress of Antimicrobial Chemotherapy (ICC) on "Microbial Theranostics - ...
Read moreE-module: Respiratory tract infections ...
ISAC is pleased to announce the launch of its first e-module which has been created as part of the ISAC ...
Read moreDeciphering the mechanisms of ...
This is the third talk in the series of webinars on "When pharmacometrics and systems pharmacology meet infectious disease" organised ...
Read more
32nd ICC on-demand
We are pleased to share the plenary and keynote lectures from the 32nd International Congress of Antimicrobial Chemotherapy (ICC) which was held in Perth, Australia in November 2022.
Sign up to ISAC's YouTube Channel to be the first to watch more excellent plenary and keynote lectures from the 32nd ICC which are posted weekly.
ICC lectures
Plenary 1: Microbial Theranostics - a Resistance Combatting Strategy
Prof. Robin Patel
In this lecture, Prof. Patel presents a potential strategy to help in the fight against the global antimicrobial resistance crisis through better diagnostics and better use of diagnostics.
Prof. Patel was awarded the Hamao Umezawa Memorial Award (HUMA) which is the highest award given by ISAC for outstanding contributions in the field of antimicrobial chemotherapy. The award is generously sponsored by the Microbial Chemistry Research Foundation of Japan.
Plenary 2: Treatment of multidrug resistant Pseudomonas aeruginosa infections
Prof. Juan-Pablo Horcajada
Topics discussed include:
* Importance and frequency of MDR Pseudomonas aeruginosa infections
* High-risk clones. Mechanisms of resistance
* Treatment with colistin
* Hollow fiber model applied to P. aeruginosa infections
* Current antimicrobial options
